Brazil records 14,000+ lymphoma cases yearly; early detection key to treatment

Over 14,000 Brazilians diagnosed annually with lymphoma; 4,812 deaths recorded in 2020, impacting patients and families through prolonged treatment protocols.
The disease is common, the symptoms are knowable, and the stakes are absolute.
Why early detection of lymphoma matters in Brazil, where 14,000 new cases are diagnosed each year.

Lymphomas affect lymphocytes in the lymphatic system; Brazil sees 14,000+ new cases yearly with 4,812 deaths recorded in 2020. Key symptoms include painless swollen lymph nodes, night sweats, fever, and unexplained weight loss; diagnosis requires biopsy and histopathological analysis.

  • 14,000+ new lymphoma cases diagnosed annually in Brazil
  • 4,812 deaths from lymphoma recorded in 2020 (4,357 non-Hodgkin, 455 Hodgkin)
  • Eighth most common cancer in Brazil; affects roughly 6 per 100,000 people
  • More than 40 lymphoma subtypes exist; diagnosis requires surgical biopsy and histopathological analysis
  • Some lymphoma types are considered curable with early detection and available therapies

Brazil registers over 14,000 new lymphoma cases annually, making it the eighth most common cancer. Early detection through awareness of symptoms like swollen lymph nodes and unexplained weight loss is crucial for effective treatment.

Every year, more than 14,000 Brazilians receive a diagnosis that will reshape their lives: lymphoma. The disease attacks the lymphocytes—the immune system's foot soldiers—and takes root in the lymph nodes scattered throughout the body. It is the eighth most common cancer in Brazil, striking roughly six people per 100,000. In 2020, the most recent year with complete mortality data, 4,812 people died from it: 4,357 from non-Hodgkin lymphoma and 455 from Hodgkin lymphoma.

Lymphoma comes in more than 40 subtypes, a complexity that makes diagnosis both critical and demanding. The disease operates in two distinct patterns. Hodgkin lymphoma spreads methodically, moving from one cluster of lymph nodes to the next through the lymphatic vessels in an orderly progression. Non-Hodgkin lymphoma, by contrast, spreads chaotically, appearing anywhere the lymphatic tissue exists. Ricardo Bigni, a hematologist and chief of the Hematology Section at the National Cancer Institute's Hospital do Câncer I in Rio de Janeiro, explains that non-Hodgkin lymphoma alone encompasses more than 20 distinct types. The most common are diffuse B-cell lymphomas, accounting for 30 percent of cases, followed by follicular lymphomas at 22 percent, then mantle cell lymphomas, marginal zone lymphomas, and others.

The early warning signs are often subtle enough to miss or dismiss. Painless swelling in the lymph nodes of the neck, armpits, or groin should raise attention. So should excessive night sweats, unexplained fever, persistent itching, fatigue that won't lift, and weight loss exceeding 10 percent without clear cause. When Hodgkin lymphoma settles in the chest, patients may develop a cough, shortness of breath, or chest pain. In the pelvis or abdomen, it produces discomfort and abdominal bloating. The challenge lies in distinguishing lymphoma from benign causes. Infections and inflammatory diseases also swell lymph nodes, but those typically hurt when touched. Lymphoma nodes remain painless. Bigni notes that when a swollen lymph node persists for weeks rather than days, infection becomes less likely, and investigation begins in earnest.

Identifying risk factors has proven difficult. In most cases, no clear cause emerges. Yet exposure to radiation and certain chemicals—benzene and some pesticides among them—can elevate risk, particularly for workers in occupational settings where such exposure occurs. People with compromised immune systems, including those infected with Epstein-Barr virus or HIV, face heightened vulnerability. Unlike many cancers, lymphoma has no established prevention strategy. The only reliable defense is early detection.

Diagnosis demands precision. A surgical biopsy is mandatory—typically a sample taken from an enlarged lymph node—sent to a pathologist for histopathological examination. Immunohistochemical analysis must be included to determine the exact lymphoma classification. Doctors may also order lumbar puncture, CT scans, and MRI to map the disease's extent and character. Only then can treatment be tailored.

The therapeutic approach varies by lymphoma type, stage, and location, and must account for the patient's overall health and any existing conditions like heart or lung disease. Chemotherapy forms the backbone of treatment, often combined with radiotherapy and immunotherapy—a method that harnesses the patient's own immune system to fight cancer cells. Some regimens use oral medications; others deliver drugs intravenously through polychemo­therapy. Bigni emphasizes that some lymphoma types are considered curable with available therapies, particularly when caught early. The window between diagnosis and advanced disease can mean the difference between remission and a far grimmer outcome. On May 15th, World Lymphoma Awareness Day serves as an annual reminder: the disease is common, the symptoms are knowable, and the stakes of catching it early are absolute.

The best approach to lymphoma is early detection and diagnosis, which can allow treatment at less advanced stages, with some types considered curable with available therapies.
— Ricardo Bigni, hematologist and chief of Hematology Section, National Cancer Institute Hospital do Câncer I, Rio de Janeiro
When a swollen lymph node persists for weeks rather than days, infection becomes less likely, and investigation for lymphoma begins.
— Ricardo Bigni, hematologist
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does lymphoma matter as a public health story right now in Brazil?

Model

Because 14,000 new cases a year means someone in Brazil is being diagnosed roughly every 40 minutes. That's not rare. And most people don't know what to look for.

Inventor

What makes early detection so critical here?

Model

The difference between catching it at stage one versus stage three can be the difference between a curable disease and one that requires years of aggressive treatment. Some types are actually curable if you catch them early.

Inventor

But the source says there's no real prevention. How do you prevent something you can't prevent?

Model

You don't. That's the hard truth. You can avoid benzene and follow workplace safety protocols, but for most people, there's no clear cause and no clear shield. So the entire strategy shifts to knowing the symptoms and getting to a doctor fast.

Inventor

The symptoms sound vague—swollen nodes, night sweats, weight loss. How does a person know it's not just a bad winter?

Model

That's the trap. A swollen node from an infection hurts. A lymphoma node doesn't. And if it's still there after weeks, not days, that's when you stop assuming it's temporary.

Inventor

And then what? The diagnosis process sounds invasive.

Model

It is. You need a surgical biopsy, lab analysis, imaging. It's thorough because the treatment depends entirely on knowing which of 40 subtypes you have. Get it wrong and the whole approach fails.

Quer a matéria completa? Leia o original em CNN Brasil ↗
Fale Conosco FAQ